/Investor DB

DNA Capital

Venture capitalActively deploying

São Paulo · Seed–Late Stage · 16 people tracked

Find your way into DNA Capital

Sign up to see every warm intro you have to DNA Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the DNA Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

DNA Capital concentrates exclusively on the healthcare sector, investing across the full lifecycle of companies from early-growth through late-stage. The firm emphasizes long-term partnerships and flexibility to participate at any stage of a company's development. It leverages a network of specialist advisors, an operating team, and an investment team that work together to deliver expertise and comprehensive support across its verticals, aiming to contribute to each company's value-creation journey. Its portfolio is global and spans multiple development stages, with activity across venture capital and private equity including Series A, Series B, growth, and late-stage investments.

Source: firm website, verified Oct 25, 2026.

Stage
Seed–Late Stage
Check
$100K – $5M
HQ
São Paulo, BR
Leads rounds
Leads
Instruments
Equity
Founded
2025
Last 12 months
3 investments
Tracked investments
21
Acquisitions
1

Team · 16 people

from the firm's website & public directories
Gian Carlo Di Tommaso· Partnerin
Sergio Ricardo Santos· Partnerin
Camila Guimarães· Chief Legal Officer, Compliance, Risk, AML, ESGin

Camila Guimarães joined DNA Capital in 2019 as Chief Legal Officer, overseeing Compliance, Risk, AML, and ESG. She previously served as Legal Counsel at Farallon Capital Management's São Paulo office and worked as a lawyer at Stocche Forbes Advogados. She holds a double bachelor's degree in Business Administration and Law from Fundação Getulio Vargas (FGV).

Daniel Studart· Analyst, Private Equityin

Daniel Studart is a private equity analyst at DNA Capital, based in São Paulo. He previously worked on the private equity team at Pátria Investimentos, where he covered the food and beverage sector before moving to the M&A team of a food retail portfolio company. He holds a degree in Civil-Aeronautical Engineering from the Instituto Tecnológico de Aeronáutica (ITA).

Henrique Bandeira· Associatein

Henrique Bandeira is an associate at DNA Capital working on venture capital investments. He previously spent over five years in M&A and strategic consulting at ADVISIA OC&C and Oliver Wyman, and worked two years at an educational NGO. He holds a bachelor's degree in Chemical Engineering from Universidade Federal do Rio Grande do Sul.

José Eduardo Guinle· Partnerin𝕏

José Eduardo Guinle is a partner at DNA Capital working on venture capital investments. He previously worked in the firm's private equity practice investing in growth and later-stage companies, and began his career in EBX Holding's corporate finance and legal team. He holds an LL.B. from Pontifícia Universidade Católica do Rio de Janeiro, has finance training from COPPEAD-UFRJ, and holds the CGE certification from ANBIMA.

Julia Prado· Analystin

Julia Prado is a private equity associate at DNA Capital, based in São Paulo. She previously worked on the private equity team at Pátria Investimentos in the M&A team of Crop Care Holding, and earlier spent two years as a private equity analyst and three years as a wealth management analyst at Icatu Holding. She is a CFA Charterholder and holds a bachelor's degree in Industrial Engineering from Pontifícia Universidade Católica do Rio de Janeiro.

Lucas Cortez· Vice Presidentin

Lucas Cortez is a Vice President at DNA Capital working on venture capital investments. Before joining the firm, he spent five years as an analyst and associate at ADVISIA OC&C, working on projects across multiple sectors. He holds a bachelor's degree in Mechanical Engineering from Universidade Estadual de Campinas and the CGE certification from ANBIMA.

Luiz Felipe Costa· Partnerin

Luiz Felipe Costa is a partner at DNA Capital, focused on private equity and based in São Paulo. Before joining the firm, he was a founding partner at Stocche Forbes Advogados and a partner at Machado Meyer Advogados, with over 20 years of experience in law and cross-border M&A transactions. He holds a B.Sc. and an LLM in Law from Universidade de São Paulo.

Luiz Noronha· Partnerin

Luiz Noronha is a partner at DNA Capital working on venture capital investments, with more than fifteen years of experience investing in early-stage companies. Before DNA Capital, he invested in technology companies at DGF Investimentos and earlier worked on the investment team of Ficus Investimentos, where he served as a board member and CFO of a portfolio company. He earned a Bachelor of Science in Mechanical Engineering from Universidade de São Paulo.

Mario Sergio Ribeiro· Partnerin

Mario Sergio Ribeiro is a partner at DNA Capital focused on private equity. Before DNA Capital, he worked in asset management at Banco Bozano, was Vice-President at One Health, and Sales Manager at Grupo Amil. He holds an Economics degree from Instituto Brasileiro de Mercado de Capitais and an MBA in Business Administration and Marketing from Fundação Instituto de Administração, with additional executive education at INSEAD and Singularity University.

Partha Mishra· Partnerin𝕏

Partha Mishra is a partner at DNA Capital focused on venture capital investments. He previously served for 12 years as president and CEO of Optum Global Solutions, the healthcare technology and services unit of UnitedHealth Group, and earlier held healthcare leadership roles at Cognizant and Capgemini. He holds a bachelor's degree in electrical engineering technology from VSS University of Technology and an MBA from the Xavier Institute of Management in India.

Pedro Bueno· Partnerin

Pedro Bueno is a partner at DNA Capital and serves as CEO of the company formed by the merger of diagnostics firm DASA and hospital chain Rede Ímpar, sitting on the boards of both. He started in investment banking at BTG Pactual working on M&A transactions, then joined Amil in 2012 and took part in its sale to UnitedHealth Group before becoming CEO of DASA. He holds a B.A. in Economics from Pontifícia Universidade Católica do Rio de Janeiro.

Ricardo Lima· Chief Financial Officerin

Ricardo Lima is the CFO at DNA Capital. He previously spent five years as a controller at Viveo S.A., where he took part in more than 25 acquisitions and the company's 2021 IPO, and earlier held roles as CFO of oil and gas company Maxen, M&A manager at A Geradora, and investment professional at DGF Investimentos, Pulsar Invest, and GG Investimentos. He holds a degree in Business Administration from FGV-EAESP.

Thayan Hartmann· Partnerin

Thayan Hartmann is a partner on the private equity team at DNA Capital. Before joining the firm, he was an associate in the private equity team at Angra Partners. He is a CFA Charterholder, a Securities Portfolio Manager authorized by the CVM, and holds the CGA designation from ANBIMA, along with a degree in Aerospace Engineering from the University of São Paulo.

Chris Hillin

Founder mafia

2 people who came through DNA Capital went on to found or lead other companies.

What they invest in

from 12 of 21 portfolio companies

Digital Health ×9Healthtech ×8AI & Machine Learning ×4Enterprise Software ×3SaaS ×3HR Tech ×2Medical Devices ×2Mental Health ×2

HQs:United States×5Brazil×4Australia×1Israel×1

Investments · 21 tracked

founders shown can be your intro path

By year:2026 · 32025 · 12022 · 22021 · 22020 · 12019 · 312 dated

Beep Saúdebeepsaude.com.brin𝕏Series A · May 2020 · $2M

Beep is a fully digital home healthcare service that provides laboratory tests (5,000+ types), vaccines, and infusions at the patient's home, booked via its app or website.

Digital HealthHealthtech

Vander Corteze(Founder)Vander Vinícius Corteze(Founder)

Co-investorsThe Lightsmith GroupValor Capital GroupWormhole CapitalActyus

Curedcured.healthin𝕏Series A · Sep 2021 · $10Macquired by Innovaccer · Jan 2024

Cured builds cloud-based enterprise software for healthcare organizations to modernize operations and improve patient and employee experiences.

AI & Machine LearningCloud ComputingDigital HealthEnterprise SoftwareHealthtechMarketing TechSan Francisco, US

Rohit(Co-Founder and Chief Customer Officer)inAshmer Aslam(Executive Officer, Director)inAndrew Sawyer(Executive Officer, Director)in

Co-investorsCU Healthcare Innovation FundHeadwater VenturesHigh AlphaMatchstick VenturesWaterline Ventures

Curie Biocurie.bioin

Curie.Bio is a biotech venture firm pairing seed capital with in-house drug discovery support for therapeutics founders.

Zach Weinberg(Founder)inAlexis Borisy(Founder)Christoph Lengauer(Founder)

Co-investorsAlleyCorpARCH Venture PartnersBoxGroupF-Prime CapitalGV (Google Ventures)Lightstone Ventures+5 more

Dasadasa.com.br

Dasa operates a broad network of laboratories and healthcare professionals in Brazil, offering diagnostic and health services spanning prevention to treatment for patients, physicians, and companies.

Digital HealthHealthtechMedical Devices

Figmentsplotdrive.cominSeedDefunct

Figments built narrative games, virtual influencers, AI characters, and creative tools over seven years, culminating in Plotdrive, an AI writing engine for long-form storytelling.

AI & Machine LearningCreator EconomyEnterprise SoftwareMedia & EntertainmentSaaSLos Angeles, US

Jay Rosenkrantz(Founder)inScott Rosenkrantz(Co-founder \u0026 Head of Product)in

Co-investorsTRANSCENDY CombinatorAscensive AssetsBDMII2BF Global Venturesmark vc+6 more

Inspiraliinspirali.cominNov 2021 · $180M

Inspirali operates a network of medical schools in Brazil, offering medical education focused on integral health care.

Digital HealthEdTechMental Health

Memedmemed.comin𝕏May 2026 · $14M

MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesIsrael, IL

Eran Eden(Co-founder and CEO)in

BoardOri Hadomi(Chairman of the Board of Directors)

Co-investorsHorizons VenturesMetaplanetQualcomm VenturesUnion Tech VenturesWestern Technology InvestmentBridge One+4 more

Memedmemed.com.brinMay 2026

Memed operates a digital prescription platform in Brazil that connects physicians, patients, pharmacies, pharmaceutical companies, and health institutions.

Digital HealthHealthtechSaaS

Marcel Ribeiro(Founder)inRicardo Moraes(Founder)inRené Moraes(Founder)in

Co-investorsDGFMONASHEESBridge One

Nice Healthcarenice.healthcarein𝕏Series A · Jun 2025 · $30M

Nice Healthcare provides on-demand primary care and health services that come to patients' locations, aiming to reduce costs and improve accessibility compared to traditional clinic-based care.

Digital HealthEnterprise SoftwareHealthtechRoseville, US

Thompson Aderinkomi(Co-Founder & CEO)inGenevieve Swenson(Co-Founder & COO)in

BoardAllison Santos(Co-Founder & Chief Business Officer)inRobert M. Greenglass(Director)Partha Sarathi Mishra(Director)in

Co-investorsConductive VenturesGaingelsGROOVE CAPITALHeadwater VenturesThe Gramercy FundWaterline Ventures+1 more

Reemareemahealth.comin𝕏Seed · Mar 2022 · $8M

Reema Health provides a personalized, community-based care model that connects people to health care and social support services in their local communities.

Digital HealthHealthtechImpact & Social GoodMental HealthMinneapolis, US

Justin Ley(CEO)inMatt(Chief Product Officer)

BoardHelen Ciesielski(Director)inMatthew Swanson(Director)Ellen Herlacher(Director)inAmon Anderson(Director)

Co-investorsAcumen AmericaDigitalis VenturesGROOVE CAPITALHC9 VenturesHeadwater VenturesLRVHealth+4 more

The Mom Projectthemomproject.comin𝕏Jul 2026

The Mom Project operates an AI-powered marketplace that matches mothers and allies with employment opportunities at companies across various sectors, offering flexible remote, hybrid, and onsite roles.

AI & Machine LearningB2B MarketplacesFuture of WorkHR TechMarketplaces

Tricia House(President & COO)inAllison Robinson(Founder)

Co-investors7GC & CoAtlanta SeedBBG VenturesGrotech VenturesHigh AlphaIngeborg Investments+10 more

Vitablevitable.com.auin

Vitable offers personalised daily vitamin and supplement subscriptions, using an online quiz developed with naturopaths, nutritionists, and pharmacists to tailor recommendations to a person's health goals, lifestyle, and diet.

ConsumerDirect to ConsumerWellness & FitnessSydney, AU

Ilyas Anane(Co-Founder)inLarah Loutati(Co-Founder & CEO)in

Co-investorsBrenteca InvestmentsCoughdrop CapitalFlying Fox VenturesRocket Internet SEScale InvestorsArtesian+5 more

Vitable Healthvitablehealth.comin𝕏Seed

Vitable provides a health benefits platform offering affordable, accessible healthcare to employers and their employees, with a focus on serving everyday workers and low-income populations.

Digital HealthHealthtechHR TechInsurTechSaaSPhiladelphia, US

Joseph Kitonga(Founder)inRon Davidson(Head of Strategy and Ops)Farabi Sameer(Product)Kyle Self(Demand Gen)Amanda Matz(Recruiting Manager)Chrisantha Pinto(Chief of Staff)

Co-investorsCherryrock CapitalCoalition OperatorsCommerce VenturesFirst Round CapitalNVP CapitalOpen Opportunity Fund+13 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

blüümFeegowFeegow ClinicNefroClínicasPiwiSanarThe CareVoiceViveo

Exits · 1

1 acquisitions

Curedacq. by Innovaccer

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has DNA Capital made?
DNA Capital has 21 tracked investments, 1 of which have exited, including 4 dated in the last 24 months.
What stage does DNA Capital invest at?
DNA Capital invests at the Seed, Series A, Series B, Growth, Late Stage stages.
What is DNA Capital's typical check size?
DNA Capital typically writes checks of $100K – $5M.
What sectors does DNA Capital focus on?
DNA Capital focuses on Biotech, Digital Health, Healthtech.
Where is DNA Capital located?
DNA Capital is headquartered in São Paulo, BR.
Does DNA Capital lead rounds?
Yes, DNA Capital leads investment rounds.
Who does DNA Capital co-invest with?
DNA Capital most often shares deals with Wormhole Capital, Conductive Ventures, GV (Google Ventures), among 22 tracked co-investors.

Images

DNA Capital photo

Co-investors · 6

High Alpha

High Alpha is a venture firm that creates and funds B2B SaaS companies, partnering with founders to build enterprise software businesses. It operates a venture capital arm (Capital) and a company-building arm (Studio).

Both backed · 2
Matchstick Ventures

Matchstick Ventures is an early-stage venture firm that backs ambitious founders 'between the coasts,' partnering at the pre-seed and seed stages with capital, time and resources.

Both backed · 2
$500K – $1.5M
HC9 Ventures

HC9 Ventures is an early-stage venture capital firm investing in healthcare companies, drawing on the industry expertise of its limited partners and advisors to help build and grow its portfolio.

Both backed · 1
Valor Capital Group

Valor Capital Group is a cross-border venture fund connecting the US, Latin American, and global technology markets, investing in consumer internet and enterprise software companies.

Both backed · 1
$100K – $5M
Redpoint eventures

Redpoint eventures is a venture capital firm supporting technology entrepreneurs in Latin America, combining local presence with the global network and track record of a Silicon Valley VC. It offers insight, company building, financing and exit support.

Firms observed investing alongside DNA Capital, from public investor directories. Shared companies are the overlap with DNA Capital's recorded portfolio.

Similar investors

Featured in lists